Intrepid Eye Society Conversations and Consensus Shaping the Future of Presbyopic Drops: Clinical Insights and Practical Strategies

Introduction

Presbyopia remains one of the most ubiquitous visual challenges that eye care providers (ECPs) encounter in clinical practice. As patients reach their fifth & sixth decades of life, the inevitable loss of accommodative amplitude drives them into your chair seeking solutions. Historically, management strategies relied heavily upon optical compensation, primarily through reading glasses, bifocals, or multifocal contact lenses. Surgical interventions, while effective for some, present risk profiles that may make numerous patients hesitant. [NEI 2024]

In recent years, a fundamental shift has slowly and quietly taken place in how we currently approach this condition. Pharmacological management of presbyopia is transforming the landscape of comprehensive eye care. By offering FDA-approved presbyopic eye drops, ECPs can provide a non-invasive, medically driven alternative that meets the demands of a highly active and socially conscious aging population.